WHO ICTRP trial
A prospective study comparing the clinical benefits of three antiemetic regimens…
ChiCTR2000040693 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2000040693 |
|---|---|
| Public title | A prospective study comparing the clinical benefits of three antiemetic regimens containing fosapitan in preventing nausea and vomiting caused by hematopoietic stem cell transplantation pretreatment chemotherapy |
| Scientific title | A prospective study comparing the clinical benefits of three antiemetic regimens containing fosapitan in preventing nausea and vomiting caused by hematopoietic stem cell transplantation pretreatment chemotherapy |
| Primary sponsor | Department of Hematology, Xiangya Third Hospital, Central South University |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Countries | China |
| Conditions | Diseases of blood system |
| Interventions | I:Fosapitam 150mg (Day1) ;II:Fosapitam 150mg (Day1-3-5-7);III:Fosapitam 150mg (Day1-5-9) |
| Registration date | Dec 8, 2020 |
| Target size | I:67;II:67;III:67 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: